A Clinical and Para-Clinical Comparison of Complicated and Uncomplicated Brucellosis in Patients Referred to Imam Hossein Hospital since 2001 to 2017 comparison of complicated and uncomplicated brucellosis
Novelty in Biomedicine,
Vol. 10 No. 1 (2022),
31 January 2022
,
Page 27-33
https://doi.org/10.22037/nbm.v10i1.35902
Abstract
Background: Brucellosis is one of the most prevalent zoonoses, with an annual incidence of half a million cases
globally. Most parts of Iran are endemic for Brucellosis. Given the worse prognosis, knowledge and early
diagnosis of the complicated forms is especially important. The present study aimed to identify the clinical and
paraclinical predictive alarms for complications in Brucellosis.
Materials and Methods: This study was done as a retrospective study on records of inpatients suffering active
Brucellosis in Imam Hussein Medical Center, SBMU, Tehran in 15 years (2001April-2016 March) as the census.
Epidemiological, clinical, and laboratory data were collected in the formerly prepared questionnaire. According
to their clinical and paraclinical findings, cases were studied in two groups: Complicated and Uncomplicated.
All data were analyzed and compared using SPSS version 19.0 ANOVA and K2 tests (P values < 0.05).
Results: In 95 patients suffering Brucellosis, 56 (59%) were male, and 39 (41%) were female. 69 (73%) cases
were evaluated as uncomplicated, and 26 (28%) cases were as complicated. 11(28%) of females and 20 (35%)
male cases were complicated without significant statistical difference. Arthritis was the most common form,
followed by the nervous system. The mean patient age was 35.46 22.2 years, (ranging 1- 86) with no
difference in two groups and different complications. The frequency of the previous history of Brucellosis and
unpasteurized dairy product use was more common in complicated cases but was not significant. Myalgia
(92% vs. 50%) and fever (50% vs. 9%) were significantly more common in complicated Brucellosis. Lab test
results had no significant mathematical difference.
Conclusion: Myalgia and fever were significantly more common in complicated Brucellosis. There was no
significant difference in other classical symptoms of Brucellosis as sweating, malaise, fatigue, and chills between the two groups and no significant difference in serologic tests titer and lab tests.
- Brucellosis, Diagnosis, Complication, Prediction
How to Cite
References
Georgios Pappas, Photini Papadimitriou, Nikolaos Akritidis, Leonidas Christou, Epameinondas V Tsianos, The new global map of human brucellosis, Lancet Infect Dis 2006;6:91–99.
Al Dahouk S, Schneider T, Jansen A, Nockler K, Tomaso H, Hagen RM, et al. Brucella endocarditis in prosthetic valves. Can J Cardiol. 2006;22(11):971-4.
Golshani, Maryam Golshani and Saeid BuozariA Review of Brucellosis in Iran: Epidemiology, Risk Factors, Diagnosis, Control, and Prevention., Iran Biomed J. 2017;21(6):349–359.
Dean AS, Crump L, Greter H, Hattendorf J, Schelling E, Zinsstag J Clinical manifestations of human Brucellosis: a systematic review and meta-analysis. - Trop Dis. 2012;6 (12);e1929.
Yujing Shi, Gao H, Pappas G, Chen Q, Li M, et al. Correction: Clinical features of 2041 human brucellosis cases in China. PLOS ONE. 2019;14(6):e0219110.
Mandell, Douglas & Bennett. Principles and Practice of Infectious Diseases. 9th ed. Philadelphia: Churchill Livingston; 2019: 2753-2758.
Turan Buzgan, Mustafa Kasim Karahocagil, Hasan Irmak, Ali Irfan Baran, Hasan Karsen, Omer Evirgen, Hayrettin Akdeniz; Clinical manifestations and complications in 1028 cases of Brucellosis, International Journal of Infectious Diseases. 2010;(14):e469–478.
Shigang Zhao, Yan Cheng, Yali Liao, Zhelin Zhang, Xuhua Yin, Shujun Shi; Treatment Efficacy and Risk Factors of Neurobrucellosis, Med Sci Monit. 2016;22:1005-12.
Mohammad Zeinali and et al; IRIB National Guideline of Brucellosis, Tehran, Raznahan,1392.
Bircan Kayaaslan, Aliye Bastug, Emsal Aydin, Esragul Akinci, Ayse But, Halide Aslaner, Meltem Arzu Yetkin & Hurrem Bodur (2016) A long-term survey of Brucellosis: Is there any marker to predict the complicated cases? Infectious Diseases. 2016;48(3):215-21.
Eini P, Keramat F, Hasanzadeh Hoseinabadi M. Epidemiologic, Clinical and Laboratory Findings of Patients with Brucellosis in Hamadan, West of Iran. J Res Health Sci. 2012;12(2):105-8.
Rongjiong Zheng, Songsong Xie, Xiaobo Lu, Lihua Sun, Yan Zhou, Yuexin Zhang, Kai Wang; A Systematic Review and Meta-Analysis of Epidemiology and Clinical Manifestations of Human Brucellosis in China, BioMed Research International. 2018;(1):1-10.
Panos Andriopoulos Maria Tsironi, Spiros Deftereos, Athanassios Aessopos, Giorgos Assimakopoulos; Acute brucellosis: presentation, diagnosis, and treatment of 144 cases, International Journal of Infectious Diseases. 2007(11):52-7.
Gulşen Mermut, Onur Ozgenc, Meltem Avcı, Ali Ilgın Olut, Ebru Oktem, Vecdi Evren Genc, Alpay Arı, Seher Ayten Coskuner; Clinical, Diagnostic and Therapeutic, Approaches to Complications of Brucellosis: An Experience of 12 Years, Med Princ Pract. 2012;21:46–50.
Shahrzad Nematollahi, ErfanAyubi, Manoochehr Karami, Salman Khazaei, Masoud Shojaeiane, RezaZamanie, KamyarMansorif, Behzad Gholamalie; Epidemiological characteristics of human Brucellosis in Hamadan Province during 2009–2015, International Journal of Infectious Diseases. 2017;(61):56–61.
Reza HRM, Zahra M, Mohseni AZ, Soheil E. Risk Factors for Relapse of Human Brucellosis. Global Journal of Health Science. 2015;8(7):77-82.
Dilek I, Durmus A, Karahocagil MK, Akdeniz, H, Karsen H, Baran AI, Evirgen O: Hematological complications in 787 cases of acute Brucellosis in Eastern Turkey. Turk J Med Sci. 2008;38:421-4.
Marc EWMD. Senescence of the Immune System. Med Clin N Am. 1983;67(2):263-72.
K.A.Franc, R.C.Krecek, B.N.Hasler, A. M. Arenas- Gamboa Brucellosis remains a neglected disease in the developing world: A call for interdisciplinary action BMC Public Health. 2018;18(125):1-9.
Javier Ariza, Juan Corredoira, Roman Pallares, Pedro Fernández Viladrich, Characteristics of and Risk Factors for Relapse of Brucellosis in Humans; CID. 2020;(5):1241-9.
Alavi SMR, Alavi L. Relapsed human brucellosis and related risk factors. Pak J Med Sci. 2009(1):46–50.
Solera J, Martınez-Alfaro E, Espinosa A, Castillejos ML, Geijo P, Rodrıguez-Zapata M. Multivariate model for predicting relapse in human brucellosis. J Infection. 1998;36(1):85-92.
Solis GDPJ, Solera J. Systematic review and meta-analysis of randomized clinical trials in the treatment of human Brucellosis. Plos One. 2012;7(2): e32090.
- Abstract Viewed: 101 times
- pdf Downloaded: 134 times